B013

· Shanghai Jiaolian Drug Research and Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for B013, covering 2025-01-27 to 2025-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer [Phase 2, Phase 3]

See pricing